In Case You Missed It: NACDS Health Care Outlook 2023 in Chain Drug Review
The NACDS-authored column previews the policy outlook for the coming year — and what lies ahead for the future of the industry.
The NACDS-authored column previews the policy outlook for the coming year — and what lies ahead for the future of the industry.
Inclusion of the INFORM Consumers Act marks a major bipartisan step toward curbing the organized retail crime networks jeopardizing Americans’ safety.
NACDS details actions needed by Biden Administration and Congress to prevent forced rollback
Through NACDS 2023, the Association continues to advance consumer-empowered, community-focused health and wellness.
It is a two-year anniversary that patients and pharmacies can appreciate. With a unanimous decision on December 10, 2020, the U.S. Supreme Court upheld an Arkansas law that confronts the damaging tactics of prescription-drug middlemen known as pharmacy benefit managers (PBMs). NACDS had submitted an amicus brief in this case, Rutledge, Attorney General of Arkansas v. Pharmaceutical Care Management Association (PCMA).
ADM Brett P. Giroir, MD, receives 2022 Excellence in Patient Care Award.
Hot and emerging topics — and critical issues — facing the industry and the nation will be front-and-center.
Brings comprehensive knowledge of state and federal regulatory and legislative matters to NACDS’ advocacy efforts.
NACDS Foundation today announced the participants for the 2022-2023 Faculty Scholars Program.
Continues momentum in Tennessee and nationwide to advance patients’ health, convenience, and savings by confronting PBM tactics.